Your browser doesn't support javascript.
loading
Recurrence of Retinopathy of Prematurity After Intravitreal Ranibizumab Monotherapy: Timing and Risk Factors.
Lyu, Jiao; Zhang, Qi; Chen, Chun-Li; Xu, Yu; Ji, Xun-Da; Li, Jia-Kai; Huang, Qiu-Jing; Zhao, Pei-Quan.
Afiliación
  • Lyu J; Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang Q; Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen CL; Department of Ophthalmology, Shengli Oilfield Central Hospital, Dongying, Shan Dong Province, China.
  • Xu Y; Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ji XD; Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li JK; Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huang QJ; Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhao PQ; Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Invest Ophthalmol Vis Sci ; 58(3): 1719-1725, 2017 03 01.
Article en En | MEDLINE | ID: mdl-28324112
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retina / Retinopatía de la Prematuridad / Ranibizumab Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Newborn Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2017 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retina / Retinopatía de la Prematuridad / Ranibizumab Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Newborn Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2017 Tipo del documento: Article País de afiliación: China